beta

EBACU

European Biotech Acquisition Corp

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

European Biotech Acquisition Corp. was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company intends to focus on identifying promising opportunities in the life sciences industry in Europe. The members of the management team are associated with LSP, one of Europe’s largest and most experienced healthcare investment firms.

Market Cap: 142 Million

Primary Exchange: NASDAQ

Website:

Shares Outstanding: 10.4 Million

Float: 0

Dividend: 0.0 (0.0%)

Beta: 0.0

Sector:

Industry:

Ethical Flags

Longest drawdown: 497 trading days

From: 2021-04-09 To: 2022-09-06

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud